Literature DB >> 16142350

Expression of HIF-1alpha and Glut-1 in human bladder cancer.

V Palit1, R M Phillips, R Puri, T Shah, M C Bibby.   

Abstract

HIF-1 is a heterodimer consisting of the HIF-1alpha and HIF-1beta subunits, and HIF-1alpha is the unique oxygen regulated subunit that determines HIF-1 activity. HIF-1alpha upgrades many gene products which include the glucose transporter protein 1 (Glut-1). Immunohistochemical studies using a monoclonal antibody specific for HIF-1alpha indicate that the overexpression of HIF-1alpha occurs in the most common forms of human cancer, including bladder cancer. The expression of Glut-1 in human bladder cancer is associated with poor prognosis and a low survival rate. To our knowledge, this is the first study to compare the expression of both HIF-1alpha and Glut-1 with clinicopathological characteristics in superficial and invasive human bladder cancer (all invasive bladder cancer patients received radical radiotherapy). The Kaplan-Meier survival analysis curve shows a significant association of HIF-1alpha expression with recurrence and survival in superficial bladder cancer and shows a significant association of Glut-1 with survival in invasive bladder cancer [chi2 (4)=10.52; Pr >chi2 =0.0012].

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142350     DOI: 10.3892/or.14.4.909

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  28 in total

1.  Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment.

Authors:  Gabriela R Passos; Juliana A Camargo; Karen L Ferrari; Mário J A Saad; Amilcar C de Mattos; Leonardo O Reis
Journal:  Med Oncol       Date:  2017-12-04       Impact factor: 3.064

2.  Angiogenesis in upper tract urothelial carcinoma associated with Balkan endemic nephropathy.

Authors:  Ljubinka Jankovic Velickovic; Ana Ristic Petrovic; Slavica Stojnev; Zana Dolicanin; Takanori Hattori; Hiroyuki Sugihara; Ken-ichi Mukaisho; Mariola Stojanovic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

3.  The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels.

Authors:  Yao Chen; Fang Luo; Shiqiao Luo; Zhongjun Wu; Jian Zhou
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

Review 4.  Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

Authors:  George J Netto
Journal:  Nat Rev Urol       Date:  2011-12-13       Impact factor: 14.432

5.  Glucose conjugation for the specific targeting and treatment of cancer.

Authors:  Emilia C Calvaresi; Paul J Hergenrother
Journal:  Chem Sci       Date:  2013-06       Impact factor: 9.825

Review 6.  Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Authors:  George J Netto; Liang Cheng
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

7.  Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis.

Authors:  Irem H Ozbudak; Konstantin Shilo; Fabio Tavora; Negar Rassaei; Wei-Sing Chu; Junya Fukuoka; Jin Jen; William D Travis; Teri J Franks
Journal:  Mod Pathol       Date:  2009-02-20       Impact factor: 7.842

8.  A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.

Authors:  Jonas Magno Santos Cesário; Rodrigo Barbosa Oliveira Brito; Camila Soares Malta; Chrisna Souza Silva; Yves Silva Teles Matos; Tânia Cristina Macedo Kunz; Jessica Julioti Urbano; Luis Vicente Franco Oliveira; Maria Aparecida Dalboni; Humberto Dellê
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-17       Impact factor: 2.416

9.  Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.

Authors:  Xiao-Hong Wu; Su-Ping Chen; Jian-Ying Mao; Xue-Xian Ji; Hong-Tian Yao; Shui-Hong Zhou
Journal:  Oncol Lett       Date:  2012-09-26       Impact factor: 2.967

Review 10.  Molecular aspects of tumour hypoxia.

Authors:  Saskia E Rademakers; Paul N Span; Johannes H A M Kaanders; Fred C G J Sweep; Albert J van der Kogel; Johan Bussink
Journal:  Mol Oncol       Date:  2008-03-27       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.